Skip to main content

Prestige 5 + WNV (Canada)

This treatment applies to the following species:
Company: Merck Animal Health

ENCEPHALOMYELITIS - RHINOPNEUMONITIS - INFLUENZA - WEST NILE VIRUS VACCINE, EASTERN & WESTERN, KILLED VIRUS, KILLED FLAVIVIRUS CHIMERA, TETANUS TOXOID

A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses (Eastern and Western), equine herpesviruses types 1 and 4 (EHV-1 and EHV-4), equine influenza virus type H3N8 strains EIV A/eq/Florida/RW/13, EIV A/Equine 2/Kentucky/02 American, EIV A/eq/Richmond/1/07, West Nile virus - flavivirus chimera and tetanus toxoid.

Prestige 5 + WNV Indications

This product has been shown to be effective for the vaccination of healthy horses 6 months of age or older against Eastern and Western encephalomyelitis viruses, EIV, EHV-1, EHV-4, tetanus, and West Nile Virus. Duration of immunity has been shown at 6 months for EIV. For more information regarding safety and efficacy data, go to productdata.aphis.usda.gov. This product has been shown to decrease virus shedding of EIV, EHV-1 and EHV-4, as well as to decrease encephalitis and viremia caused by West Nile Virus. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.

DOSE: For primary vaccination aseptically administer 1 mL intramuscularly, repeat with a single dose in 3 - 4 weeks. Historically, annual revaccination with this product has been recommended. The need for annual booster vaccination has not been established for this product. A booster dose can be administered at more frequent intervals based upon individual horse or farm disease risk assessment or any time epidemic conditions exist or are reported. Consult your veterinarian.

CAUTIONS: Store at 2°-8°C (35°-46°F). Shake well before using. Use entire contents when first opened. Do not mix with other products. This product has not been tested in pregnant animals. Do not vaccinate within 21 days before slaughter. Inject deep into the muscle only. Local reactions may occur at the injection sites in vaccinates, and most of these reactions resolve in 3 to 7 days following vaccination. Systemic reactions may also occur in animals following vaccination. If allergic reaction occurs, treat with epinephrine. Care should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. In case of human exposure, contact a physician.

ANTIBIOTIC: Gentamicin.

PRESERVATIVE: Thimerosal.

FOR ANIMAL USE ONLY

Intervet Inc. d/b/a Merck Animal Health, Omaha, NE 68103, USA

VLN 165A/PCN 4855.R2

1 800 521-5767 (USA)

1 866 683-7838 (CAN)

For patent information:

http://www.merck.com/product/patent/home.html

 

 

Code

 

10 Doses

10 x 1 mL Syringes with Separate Sterile Needles

192936

179589-01

10 Doses

10 mL

182299

185799-01

CPN: 1208309.0

MERCK ANIMAL HEALTH
Intervet Canada Corp.

16750 ROUTE TRANSCANADIENNE, KIRKLAND, QC, H9H 4M7
Order Desk:   514-428-7013
Toll-Free:   866-683-7838
Fax:   Toll-free 888-498-4444; local 514-428-7014
Website:   www.merck-animal-health.ca
THIS SERVICE AND DATA ARE PROVIDED "AS IS". Animalytix assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the Animalytix service and data. See the Terms of Use for further details.

Animalytix

Copyright © 2024 Animalytix LLC. Updated: 2024-02-27